A Quick Guide to CAF Subtypes in Pancreatic Cancer

A Quick Guide to CAF Subtypes in Pancreatic Cancer

Pancreatic cancer represents one of the most desmoplastic malignancies and is characterized by an extensive deposition of extracellular matrix. The latter is provided by activated cancer-associated fibroblasts (CAFs), which are abundant cells in the pancreatic tumor microenvironment. Many recent stu...

Full description

Bibliographic Details
Main Authors:	Anna Brichkina, Pierfrancesco Polo, Shrey Dharamvir Sharma, Nico Visestamkul, Matthias Lauth
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Cancers
Subjects:	tumor stroma pancreatic cancer cancer-associated fibroblast CAF stellate cell ECM
Online Access:	https://www.mdpi.com/2072-6694/15/9/2614

Similar Items

Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
by: Dale M. Watt, et al.
Published: (2021-10-01)

Apoptosis in the Pancreatic Cancer Tumor Microenvironment—The Double-Edged Sword of Cancer-Associated Fibroblasts
by: Ester Pfeifer, et al.
Published: (2021-07-01)

Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
by: Ulrike Heger, et al.
Published: (2022-08-01)

Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment
by: Jeffrey Norton, et al.
Published: (2020-05-01)

Fight the Cancer, Hit the CAF!
by: Andrea Papait, et al.
Published: (2022-07-01)

Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies
by: Kinga B. Stopa, et al.
Published: (2020-05-01)

Integrins, CAFs and Mechanical Forces in the Progression of Cancer
by: Imjoo Jang, et al.
Published: (2019-05-01)

Role of Pancreatic Stellate Cells in Chemoresistance in Pancreatic Cancer
by: Joshua eMcCarroll, et al.
Published: (2014-04-01)

Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells
by: Daniela Lenggenhager, et al.
Published: (2019-01-01)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
by: Utpreksha Vaish, et al.
Published: (2021-12-01)

Transcription factors in fibroblast plasticity and CAF heterogeneity
by: Roberta Melchionna, et al.
Published: (2023-12-01)

Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
by: Michele Montori, et al.
Published: (2022-11-01)

Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic CancerSummary
by: Ralph Francescone, et al.
Published: (2024-01-01)

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
by: Letizia Porcelli, et al.
Published: (2019-03-01)

Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Annah Morgan, et al.
Published: (2023-07-01)

Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics
by: Hideaki Ijichi
Published: (2022-10-01)

Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
by: Varintra E. Krisnawan, et al.
Published: (2020-10-01)

Contribution of bone marrow derived cells to pancreatic carcinogenesis
by: Christopher J Scarlett, et al.
Published: (2013-03-01)

Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
by: Mikkel Morsing Bagger, et al.
Published: (2024-01-01)

Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
by: Raphaël Peiffer, et al.
Published: (2022-12-01)

Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
by: Tomohiko Shinkawa, et al.
Published: (2022-08-01)

Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma
by: Taija Korpela, et al.
Published: (2022-01-01)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
by: Xinglong Geng, et al.
Published: (2021-07-01)

scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosis
by: Lvwen Ning, et al.
Published: (2024-04-01)

Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma
by: Zoe X. Malchiodi, et al.
Published: (2021-01-01)

Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Yoshiaki Sunami, et al.
Published: (2020-12-01)

The Interaction between Laminin-332 and α3β1 Integrin Determines Differentiation and Maintenance of CAFs, and Supports Invasion of Pancreatic Duct Adenocarcinoma Cells
by: Ana C. Martins Cavaco, et al.
Published: (2018-12-01)

Integrin Regulation of CAF Differentiation and Function
by: C. Michael DiPersio, et al.
Published: (2019-05-01)

TβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts
by: Bojana Jovanović, et al.
Published: (2016-11-01)

CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
by: Chunxue Zhang, et al.
Published: (2023-03-01)

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
by: Deepshikha Mishra, et al.
Published: (2023-02-01)

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
by: Neel I. Nissen, et al.
Published: (2019-03-01)

Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
by: Taku Fujimura
Published: (2022-04-01)

Simultaneous Targeting Tumor Cells and Cancer-Associated Fibroblasts with a Paclitaxel–Hyaluronan Bioconjugate: In Vitro Evaluation in Non-Melanoma Skin Cancer
by: Barbara Bellei, et al.
Published: (2021-05-01)

Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
by: Dajia Liu, et al.
Published: (2020-10-01)

Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor
by: Pang N, et al.
Published: (2018-10-01)

Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment
by: Yuma Nihashi, et al.
Published: (2023-07-01)

Reassessing Breast Cancer-Associated Fibroblasts (CAFs) Interactions with Other Stromal Components and Clinico-Pathologic Parameters by Using Immunohistochemistry and Digital Image Analysis (DIA)
by: Alina Cristina Barb, et al.
Published: (2023-07-01)

Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance
by: Kendelle J. Murphy, et al.
Published: (2021-07-01)

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
by: Amy Burley, et al.
Published: (2022-10-01)